Stock listing
ZVRA Stock Price, News, Filings & Events — Zevra Therapeutics, Inc.
Selected listing: ZVRA · NASDAQ · USD · US
This page tracks Zevra Therapeutics, Inc.'s ZVRA:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following ZVRA:NASDAQ. ZVRA:NASDAQ is the stock-level entry point for investors researching Zevra Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Zevra Therapeutics, Inc. is a public company traded under the ticker ZVRA in the American market. The company has a market capitalization of approximately $789.2 million. Zevra focuses on developing innovative therapies to address unmet medical needs.
- Ticker
- ZVRA:NASDAQ
- Asset type
- Stock
- Market cap
- $704.9M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NASDAQ
- Currency
- USD
Zevra Therapeutics, Inc. ZVRA:NASDAQ stock context
This page tracks Zevra Therapeutics, Inc.'s ZVRA:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following ZVRA:NASDAQ. ZVRA:NASDAQ is the stock-level entry point for investors researching Zevra Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Zevra Therapeutics, Inc. is a public company traded under the ticker ZVRA in the American market. The company has a market capitalization of approximately $789.2 million. Zevra focuses on developing innovative therapies to address unmet medical needs.
Latest news from Zevra Therapeutics, Inc.
Zevra Therapeutics to Present New Long-Term Real-World Data on MIPLYFFA® in Niemann-Pick Disease Type C (NPC) at the 2026 SSIEM Annual Sy...
August 25, 2026
Zevra Reports Second Quarter 2026 Financial Results and Corporate Update
August 5, 2026
Zevra Therapeutics to Present at the Canaccord Genuity Annual Growth Conference
August 4, 2026
Zevra Therapeutics Announces Publication of Four-Year Real-World Data from U.S. Early Access Program Evaluating MIPLYFFA® (arimoclomol) i...
August 3, 2026
Zevra Therapeutics Provides Update on Regulatory Submission for Arimoclomol for the Treatment of Niemann-Pick Disease Type C (NPC) in the...
July 24, 2026
Research Zevra Therapeutics, Inc.
Zevra Therapeutics, Inc. investor report
Review AI stock analysis and investor report context for ZVRA:NASDAQ.
Zevra Therapeutics, Inc. company profile
View the public company page for Zevra Therapeutics, Inc. on 6ix.
Zevra Therapeutics, Inc. news
Read company news and market updates connected to Zevra Therapeutics, Inc..
Zevra Therapeutics, Inc. investor events
Find investor webinars, events, and replay context for Zevra Therapeutics, Inc..
Alternate listings
1GDA:GETTEX
DE · EUR
Alternate listing for Zevra Therapeutics, Inc.; the primary context on this page is ZVRA:NASDAQ.
ZVRA:BOATS
US · USD
Alternate listing for Zevra Therapeutics, Inc.; the primary context on this page is ZVRA:NASDAQ.
1GDA:TRADEGATE
DE · EUR
Alternate listing for Zevra Therapeutics, Inc.; the primary context on this page is ZVRA:NASDAQ.
A2QLX7:LSX
DE · EUR
Alternate listing for Zevra Therapeutics, Inc.; the primary context on this page is ZVRA:NASDAQ.
A2QLX7:LS
DE · EUR
Alternate listing for Zevra Therapeutics, Inc.; the primary context on this page is ZVRA:NASDAQ.
1GDA:SWB
DE · EUR
Alternate listing for Zevra Therapeutics, Inc.; the primary context on this page is ZVRA:NASDAQ.
1GDA:FWB
DE · EUR
Alternate listing for Zevra Therapeutics, Inc.; the primary context on this page is ZVRA:NASDAQ.
1GDA:DUS
DE · EUR
Alternate listing for Zevra Therapeutics, Inc.; the primary context on this page is ZVRA:NASDAQ.
1GDA:HAM
DE · EUR
Alternate listing for Zevra Therapeutics, Inc.; the primary context on this page is ZVRA:NASDAQ.
1GDA:MUN
DE · EUR
Alternate listing for Zevra Therapeutics, Inc.; the primary context on this page is ZVRA:NASDAQ.